Stocks · Health care · Pharmaceutical Preparations

Johnson & Johnson

JNJ Clue Score64
United States Fiscal year ends January CIK 0000200406 Results filed 13 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Kathryn E Wengel
6 Feb 2026
EVP, Chief TO and Risk Officer
Exercised, kept
38,945
$101.87
$3.97M
Kristen Mulholland
6 Feb 2026
EVP, Chief HR Officer
Exercised, kept
5,625
$101.87
$573.02K
Timothy Schmid
6 Feb 2026
EVP, WW Chair, MedTech
Exercised, kept
15,571
$101.87
$1.59M
Elizabeth Forminard
5 Feb 2026
EVP, Chief Legal Officer
Exercised, kept
8,921
$129.51
$1.16M
Elizabeth Forminard
29 Aug 2025
Executive VP, General Counsel
Exercised, kept
11,521
$115.67
$1.33M
Jennifer L Taubert
7 Feb 2025
EVP, WWC. Innovative Medicine
Exercised, kept
58,504
$100.06
$5.85M
Kathryn E Wengel
7 Feb 2025
EVP, Chief TO and Risk Officer
Exercised, kept
32,762
$100.06
$3.28M
Joaquin Duato
7 Feb 2025
CEO and Chairman of the Board
Exercised, kept
126,369
$100.06
$12.64M
Joaquin Duato
9 Feb 2024
CEO and Chairman of the Board
Exercised, kept
130,969
$90.44
$11.84M
Kathryn E Wengel
9 Feb 2024
EVP, Chief TO and Risk Officer
Exercised, kept
35,638
$90.44
$3.22M
Joaquin Duato
17 Jan 2023
CEO and Chairman of the Board
Exercised, kept
148,538
$72.54
$10.77M
Alex Gorsky
17 Jan 2023
Director
Exercised, kept
547,692
$72.54
$39.73M
Thibaut Mongon
7 Nov 2022
Exec VP, WW Chair, Consumer
Exercised, kept
7,010
$101.87
$714.11K
Thibaut Mongon
7 Nov 2022
Exec VP, WW Chair, Consumer
Exercised, kept
10,033
$115.67
$1.16M
Showing 250 of 433 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 562
Amendments (4/A) skipped 2
Filings about a different issuer 12
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 163
Sales at will 246
Transactions with no price 0
Shares from compensation/vesting 9,708,544
Sales filed before the plan box existed 235
History held since 3 Oct 2006